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fithin the ACC’s Annual Scientific Sessions, the Special
opics area encompasses a broad range of investigations
overing subjects as diverse as assessing and improving
ardiovascular health care quality to the measurement of the
mpact of cardiovascular informatics. More than 270 ab-
tracts were submitted in the Special Topics area, and 88
ere accepted for presentation at the Scientific Sessions.
espite the breadth of subjects explored, Special Topics
nvestigations are united by their interdisciplinary nature
nd focus on identifying opportunities for improving car-
iovascular care. In the following paper, we review some of
he most important findings reported in the Special Topics
essions.
ESSONS LEARNED FROM
ARGE CLINICAL REGISTRIES
arge-scale, multicenter, prospective clinical registries have
een invaluable in exploring the many challenges faced in
ransforming clinical trial data into clinical practice. Several
f these studies have focused on the status of guideline-
ased care in acute coronary syndromes (ACS) and heart
ailure (HF). Data from these registries demonstrate signif-
cant gaps between ideal clinical performance as defined by
he ACC/American Heart Association (AHA) guidelines
nd the performance documented at the leading centers
articipating in these registries.
Investigators in the Prospective Registry Evaluating
yocardial Infarction: Events and Recovery (PREMIER),
prospective multicenter study of 2,498 acute myocardial
nfarction (MI) survivors at 19 centers, explored a variety of
ealth care topics ranging from the impact of insurance and
ocioeconomic status on clinical outcomes to long-term
ealth status after ACS. Investigators found that after
djustment for other confounders, lack of health insurance
t the time of initial hospitalization was associated with
ignificantly lower usage of statin and beta-blocker therapy
nd a lower likelihood of having an identifiable health care
rovider at six months. All of these findings indicated
oorer longitudinal treatment after acute MI (1).
Another study of the PREMIER registry investigated the
elationship of socioeconomic status of the patients to
linical outcomes after acute MI. Patients in the lowest
ocioeconomic status strata had the highest rates of all-cause
ortality and rehospitalization. After adjusting for clinical
actors, insurance, and demographics, household income
From the *Division of Cardiology, Decision Systems Group, Brigham and
omen’s Hospital, Harvard Medical School, Boston, Massachusetts; and ther
Cardiovascular Fellowship Program, Yale University School of Medicine, New
aven, Connecticut.ad a strong inverse association with mortality (2). Finally,
nother team of PREMIER investigators discovered that
here was little difference in health status at one year
etween survivors of ST-segment elevation myocardial in-
arction (STEMI) versus non–ST-segment elevation myo-
ardial infarction (NSTEMI), demonstrating the need to
ocus efforts on improving care and outcomes for the full
ange of ACS survivors (3).
Investigators from the large Can Rapid Risk Stratifica-
ion of Unstable Angina Suppress Adverse Outcomes with
arly Implementation of the ACC/AHA Guidelines
CRUSADE Initiative) provided ongoing information from
his national registry. Launched in 2001, the CRUSADE
nitiative is a national quality improvement initiative that is
esigned to increase the practice of evidence-based medi-
ine for patients diagnosed with non–ST-segment elevation
cute coronary syndromes (NSTE ACS) (i.e., unstable
ngina or NSTEMI). The ACC/AHA Guidelines for the
anagement of NSTE ACS are the “gold standard” by
hich appropriate care is defined. Through a continuous
ycle of data collection, performance feedback (via site-
pecific reports), and quality improvement interventions,
ore than 140,000 cases have been submitted to the
RUSADE Initiative.
A key component of the CRUSADE Initiative is sharing
he current state of care and acute outcomes for NSTE ACS
atients with the cardiovascular community, through both
cientific publications and presentations. At this year’s ACC
essions, investigators studied the performance of hospitals
n the management of patients with ACS and identified that
he involvement of a committed physician in the quality
mprovement (QI) process was a critical factor in achieving
igh rates of adherence to ACC/AHA class I quality
ndicators. Physician leadership in quality improvement
nitiatives was more predictive of high-quality care than
nancial resources, administrative support for QI efforts, or
se of data feedback to the clinical services (4). Now that
irect physician leadership in QI efforts has been identified
s a key predictor of health care quality, cardiovascular
eaders must rise to meet this challenge through active
articipation at their institutions, and institutions must
ecognize the importance of engaging the clinical commu-
ity in QI efforts.
Investigators of the Portuguese Registry of Acute Coro-
ary Syndromes studied the compliance with guidelines
egarding the medical therapy for the treatment of
STEMI and unstable angina. In reviewing the in-hospital
utcomes of more than 7,500 patients, the investigators
ound that complete compliance with medical therapy
ecommendations was associated with a 70% lower risk of
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ACC 2006 Annual Session Highlights June 6, 2006:D41–4n-hospital mortality. This study confirms the findings of
revious investigators who have found compliance with
CC/AHA guidelines in the treatment of ACS to be a
ritical determinant of clinical outcome (5). Separately,
nvestigators from Case Western Reserve University studied
he relationship between medical center volume of acute MI
ases treated and adherence to guideline-based care, by
xamining the 3,712 centers included in the Centers for
edicare and Medicaid Services Hospital Compare data-
ase. They found a significant and continuous improvement
n adherence rate across all studied measures as acute MI
olumes increased, confirming the adage that “practice
akes perfect” (6).
MPROVING THE QUALITY
F CARDIOVASCULAR CARE
ontinuing with the theme of optimizing acute MI care,
nvestigators from University of Michigan and Yale Univer-
ity undertook a novel exploration of the feasibility of access
o primary percutaneous coronary intervention (PCI) for
TEMI, by assessing the driving distances and times for the
.S. population to hospitals with the capabilities for per-
orming PCI. The investigators studied U.S. census tract
ata and integrated it with driving times and distances to
CI and non-PCI hospitals using a nationwide road net-
ork database. The investigators found that 79% of U.S.
dults lived within a 60-min prehospital time period that
ould make transfer to a PCI hospital feasible in the setting
f STEMI (Fig. 1), which is within the targeted door-to-
alloon time guidelines. This finding supports the feasibility
f targeting primary PCI as the therapy of choice for
Abbreviations and Acronyms
ACC/AHA  American College of
Cardiology/American
Heart Association
ACS  acute coronary syndrome
CRUSADE Initiative  Can Rapid Risk Stratification
of Unstable Angina Suppress
Adverse Outcomes With
Early Implementation of the
ACC/AHA Guidelines
HF  heart failure
MI  myocardial infarction
NSTE  non–ST-segment elevation
NSTEMI  non–ST-segment elevation
myocardial infarction
PCI  percutaneous coronary
intervention
PREMIER  Prospective Registry Evaluating
Myocardial Infarction: Events
and Recovery
QI  quality improvement
STEMI  ST-segment elevation
myocardial infarction
UFH  unfractionated heparinTEMI for most U.S. regions, if it can be provided at an axperienced center within the recommended door-to-
alloon time guidelines (7).
Another provocative study, from the University of Cali-
ornia system (Los Angeles and Irvine campuses), explored
he impact of a variety of organizational strategies to
mprove quality of care. The investigators studied 9,746
atients with diabetes from 57 provider groups and assessed
he impact of organizational incentives and processes on
ardiovascular outcomes. The authors found that higher-
ntensity use of clinical information systems was associated
ith 45% fewer admissions for congestive HF. Of impor-
ance, the investigators also determined that alignment of
nancial incentives for physicians with quality targets sig-
ificantly increased guideline adherence for lipid-lowering
herapy and was independently associated with 59% fewer
ongestive HF admissions. Conversely, increasing a physi-
ian’s gate-keeping functional role was associated with
orse adherence to guideline therapies and a 55% increase
n congestive HF admissions (8).
DENTIFYING RISKS IN CARDIOVASCULAR CARE
nother theme in the Special Topics area is the identifica-
ion of gaps or risks in the quality of cardiovascular care
rovided to patients. To that end, a series of studies
xplored the risks and consequences of medication noncom-
liance as well as health care system barriers that may
ncrease this risk. Investigators from the University of
ennsylvania probed the impact of pill burden on medica-
ion compliance by studying the proportion of days covered
or antihypertensive and lipid-lowering therapy in a retro-
pective cohort of 8,406 patients. The investigators found
hat pill burden had the greatest negative impact on medi-
ation adherence in patients taking the fewest medications
nd was a significant independent predictor of adherence to
ardiovascular medication therapy (9).
A separate investigation from the Department of Veter-
ns Affairs and Kaiser Permanente studied the impact of
edication non-adherence on hospitalization and mortality
igure. 1. Pre-hospital time periods in the U. S. Green indicates 60 min
r less; yellow indicates 60 min. Reprinted with permission (7).mong patients with diabetes. This retrospective study of
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June 6, 2006:D41–4 ACC 2006 Annual Session Highlights1,532 patients with diabetes identified that 21.3% of
atients were nonadherent to medical prescriptions (defined
s80% proportion of days covered for filled prescriptions).
onadherent patients were younger and had fewer comor-
idities. In a multivariate analysis, medication nonadher-
nce was associated with a 36% increase in all-cause hospi-
alization and a 72% increase in the relative risk of all-cause
ortality. The authors recommended assessment of medi-
ation adherence in routine clinical practice as a mechanism
or identifying these patients with a significantly increased
isk of adverse events (10).
Barriers to obtaining medically appropriate medications
ere identified as a significant risk for adverse events in two
ndependent studies. Researchers from the University of
ichigan explored the records of more than 93,000 statin
sers to estimate the relationship between co-payments for
edication and adherence to medication. They determined
hat higher co-payments were independently associated
ith a 25% reduction in the rates of adherence to statin
rescriptions. Of importance, higher rates of statin adher-
nce were associated with fewer cardiovascular hospitaliza-
ions and emergency room visits (11).
A second study from the University of Montreal explored
he impact of restrictive access for the distribution of
lopidogrel following PCI on 13,663 patients not previously
aking the medication. The investigators found that 20.1%
f patients had their prescription for clopidogrel delayed by
t least one day as compared with the prescription filling of
ther cardiac medications (12). In this subset of delayed or
nfilled prescriptions, the risk-adjusted mortality was 47%
igher at 12 months than in the medically compliant group.
his analysis highlights the critical importance of the
ttention health care delivery systems must pay toward
ccess to needed medications.
ARDIOVASCULAR INFORMATICS
he increasing use and sophistication of computer applica-
ions within cardiovascular medicine has opened new op-
ortunities for novel research in ways to identify risks to
uality of care as well as develop tools to improve delivery of
ardiovascular care. Several notable examples of cardiovas-
ular informatics research were presented at the Scientific
essions. Researchers at Harvard Medical School studied
he patterns of alerts associated with administration of
nfractionated heparin (UFH) from a computerized order
ntry system at Brigham and Women’s Hospital. A total of
01 alerts were triggered in 3,674 patients who received
FH, of which 50% were related to suspected overdosing.
eak error times for UFH administration, as evidenced by
hanges in programmed dosing following alerts, correlated
ith nursing shift times. Smart infusion pump technology
educed errors in the administration of UFH (13).
In a very different study, researchers from the National
ardiovascular Centre Research Institute in Suita-City,
apan, evaluated a closed-loop automated drug deliveryystem to optimize the management of left atrial pressure,
ardiac output, and systemic arterial pressure in a decom-
ensated congestive HF canine model. The system was able
o rapidly achieve optimized hemodynamic parameters that
tabilized within 30 min of initiation of the system in 12
ogs, thereby avoiding the frequent adjustments of drug
nfusion rates (14). Investigations such as this one may soon
ead to closed-loop automated dose titration systems for
uman trials, thereby potentially reducing human error in
osing of critical cardiovascular medications.
UMMARY
he highlights reviewed here represent only a small sample
f the novel investigations presented at the Annual Scien-
ific Sessions regarding the assessment of quality of care,
dentification of risks to effective treatment, and new hori-
ons in the use of computerized systems to support delivery
f cardiovascular care. Through assessments of the quality of
ardiovascular care delivered in practice, the entire cardio-
ascular community gains critical insight into the require-
ents for most effectively treating our patients.
eprint requests and correspondence: Dr. Frederic S. Resnic,
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